Background. Antibiotic-resistant Staphylococcus aureus is a globally emerging pathogen. Exchangeable virulence factors, such as Panton-Valentine leukocidin (PVL), have been proposed to drive this epidemic. We investigated whether skin infections and nasal colonization in travelers contribute to the global spread of such strains.
Travelers to tropical and subtropical countries are generally regarded to be at an increased risk of skin and soft tissue infections (SSTIs), although the risk factors are not well defined [1, 2] . The influence of humidity and poor hygiene on the skin and its resident flora have been proposed to explain this phenomenon [2] , but analytic research on the role of bacterial colonization in the evolution of SSTIs in travelers is lacking. Moreover, the significance of geographic differences in pathogen prevalence and virulence, which is likely to be an important component in the pathogenesis of SSTIs in travelers, has not been widely discussed.
Staphylococcus aureus is frequently isolated from purulent skin lesions in returnees from the tropics and subtropics [3] . Some strains of S. aureus have the ability to produce Panton-Valentine leukocidin (PVL), which is a pore-forming toxin that causes tissue necrosis and lysis of phagocytic leukocytes [4] . Clinical and epidemiological studies indicate that PVL-positive (PVL 1 ) S. aureus is associated with deep-seated skin abscesses and outbreaks of SSTIs [5, 6] . Although these clinical characteristics are typical of travel-associated skin infections, analytic studies on the association of PVL 1 S. aureus with clinical outcomes of SSTIs in travelers have not yet been published. Various case reports and series on PVL 1 SSTIs report recent travel, expatriation, or migration of affected individuals, thus suggesting a temporarily increased exposure to more virulent pathogens in nontemperate zones [3, [7] [8] [9] [10] [11] . The first evidence that travelers are at an increased risk of acquiring S. aureus strains that are more prevalent abroad comes from Sweden. Based on surveillance data, Stenhem et al [12] estimated that travelers to tropical and subtropical countries have up to a 59-fold higher risk of being colonized or infected with methicillinresistant S. aureus (MRSA) compared with travelers returning from countries in Western Europe. The global epidemiology, import, and transmission dynamics of PVL 1 methicillin-sensitive S. aureus (MSSA) remains understudied, because research on the epidemiology of PVL and its role as a virulence factor of S. aureus has thus far largely focused on MRSA strains. Considering the cumulating evidence on the close phylogenetic relationship between PVL 1 MSSA and community-acquired MRSA (CA-MRSA), with the former representing a potential reservoir for the local emergence of the latter [13] [14] [15] [16] [17] , investigations on the colonization and infection of returnees with PVL 1 S. aureus may improve our understanding of the global emergence and spread of more virulent and multiple antibiotic-resistant S. aureus strains. This study has the following aims: (1) to investigate the association of S. aureus-positive SSTIs in travelers to the tropics and subtropics with geographic exposure; (2) to describe the role of the S. aureus virulence factor PVL in the pathogenesis of SSTIs in travelers; and (3) to test the hypothesis of a frequent import of PVL 1 S. aureus strains through SSTIs in returnees.
METHODS

Study Population
This study was conducted between June 2007 and November 2009 at the travel clinic in Tübingen, Germany. Patients presenting with SSTIs were considered for inclusion when they reported onset of symptoms while visiting tropical or subtropical regions outside of Europe or within 30 days after returning. Exclusion criteria were a history of purulent skin infections at any time before the last stay abroad, inpatient treatment within the last year for reasons other than the underlying SSTI, preexisting or concurrent skin disease, immunodeficiency, major trauma at the onset of the SSTI, and chronic wounds. Eligible individuals were asked to provide nasal and lesional swabs, and individuals who were positive for S. aureus in the lesional swab were considered case patients. In addition, we collected information on demographic and travel-related characteristics. For each patient with an SSTI, we screened 5 returnees for eligibility to participate as control patients. These patients were randomly selected from 20 patients who had registered after the case patient. Patients presenting with symptoms unrelated to skin infections and who otherwise fulfilled the same inclusion criteria as the case patients were asked for informed consent. Identical data collection methods were applied for the case and control patients.
Laboratory Procedures
Nasal swabs were obtained by circulating a dry cotton swab 4 times in each vestibulum nasi while pressing it gently against the inner nasal wall. Swabs were stored in a transport medium (Amies) and processed within 24 hours at the Institute of Microbiology and Hygiene at the University of Tübingen Medical School, and S. aureus was identified according to standard laboratory methods. In brief, single colonies grown on sheep blood agar plates were analyzed by DNase reaction and the latex slide agglutination test (Staphytect Plus; Oxoid, Basingstoke, UK). Ambiguous isolates were additionally verified by API Staph system (bioMérieux, Nürtingen, Germany). Polymerase chain reaction for the presence of lukS/lukF genes coding for PVL was performed as described elsewhere [6] . All PVL 1 S. aureus isolates were further characterized by a DNA sequence analysis of the protein A gene variable repeat region (spa typing) [18] . Spa types were used to infer the multilocus sequence type (MLST) from entries in the Ridom SpaServer (http://www.spaserver.ridom.de/) database or the multilocus sequence typing database (http://www.mlst.net) [19] , or from genotype information published elsewhere (see Table 4 for references). Rare spa types that did not allow such assignment and all MRSA isolates were subject to MLST [20] . For the MRSA isolates, SCCmec typing was conducted as described elsewhere [21] . Pulsed-field gel electrophoresis after SmaI digestion was applied to demonstrate the relatedness of non-spa-typeable S. aureus strains [22] .
Statistical Analysis
A logistic regression analysis was used to calculate odds ratios (ORs), 95% confidence intervals (CIs), and P values for the casecontrol comparison and for the analysis of clinical characteristics by PVL status. Robust standard errors were applied to account for the clustering of cases. Two-sided Fisher exact tests were used to compare differences in proportions. All statistical procedures were performed using the Stata software package, version 10 (StataCorp, College Station, Texas).
Ethics
The study protocol was reviewed and approved by the Ethics Committee, Faculty of Medicine, Eberhard Karls Universität, Tübingen. All participants gave written informed consent.
RESULTS
Characteristics of Travelers With SSTIs
We screened 48 returnees with SSTIs and identified 38 cases with lesional swabs positive for S. aureus. Overall, 21 cases were PVL 1 MSSA, 6 were PVL 1 MRSA, 10 were PVL 2 MSSA, and 1 was PVL 2 MRSA. The predominant clinical presentation was abscesses (n 5 22) followed by furuncles (n 5 5), folliculitis (n 5 4), impetigo (n 5 4), ulcerative lesions (n 5 2), and cellulitis (n 5 1). Twenty-seven returnees with S. aureus-positive SSTIs reported recurrences, and 18 had surgical drainage since the onset of travel-related skin infections. Fifteen travelers reported SSTIs in close contacts, 6 of which were also seen at our institution: 4 were co-travelers and were thus case patients, whereas 2 were nontraveling contacts included in the study of PVL as a virulence factor only.
Comparison of Cases and Controls
We enrolled 124 control subjects suffering from travel-related conditions other than SSTIs (Table 1) . A comparison of cases and controls showed that travelers with SSTIs were more likely to have returned from Africa. Likewise, length of stay, purpose of travel, antibiotic intake within 30 days before consultation, and S. aureus nasal carriage were associated with SSTIs in returnees. By contrast, we did not find differences among groups with respect to whether continuous antimalarial chemoprophylaxis was taken. A further analysis showed that the association of geographic exposure with SSTIs was confounded by both purpose b From a univariable logistic regression analysis using robust standard errors.
c From a multivariable logistic regression analysis adjusted for travel duration and purpose of travel using robust standard errors.
d No. of patients was n 5 37 because of missing data.
e No. of patients was n 5 123 because of missing data.
f Per increase in ordered category.
g No. of patients was n 5 35 because of missing data.
h No. of patients was n 5 34 because of missing data.
i From 2-sided Fisher exact test.
and duration of travel. A corresponding adjustment strengthened the evidence for an association of S. aureus infections with travel to Africa (Table 1) .
Nasal Carriage of S. aureus and SSTIs in Returnees
Seventy-three percent of the case patients, but only 25% of the control subjects, were nasal carriers of S. aureus ( The presence of PVL in the lesional isolates was strongly associated with the presentation of abscesses or furuncles, recurrent disease, and surgical drainage. Nasal carriage of PVL 1 S. aureus was significantly more frequent in travelers suffering from recurrent lesions than in returnees with only 1 episode of an SSTI (P 5 .002). S. aureus nasal carriage, irrespective of PVL status, was not associated with any of these clinical characteristics ( Table 2 ).
Spread of PVL 1 S. aureus to Close Contacts
We found weak statistical evidence for an association of secondary infections in partners and household members of a primary case having PVL in lesional or nasal S. aureus isolates ( Table 2) .
There was also a nonsignificant trend toward an association of disease transmission with the primary case suffering from recurrent disease (OR, 5.3 [95% CI, .6-49.5]; P 5 .14). However, S. aureus nasal carriage irrespective of PVL 1 status was not associated with a skin infection in contacts. Table 3 summarizes the clusters where isolates of secondary cases were available.
Import of PVL 1 S. aureus Through Intercontinental Travel
Most of the S. aureus isolates from the skin lesions of the returning travelers belonged to spa types and/or sequence types that were previously reported in the visited regions. Forty-one percent of isolates that were spa-typed belonged to genotypes with ,0.1% of records in the RidomSpa database (Table 4) . Antibiotic resistance, particularly against trimethoprimsulfamethoxazole (TMP-SMX), was significantly more prevalent in PVL 1 MSSA compared with colonizing PVL 2 MSSA from the control patients (Table 5 ). Resistance against TMP-SMX was only found in PVL 1 S. aureus from travelers returning from Asia or Africa (P 5 .02). Resistance against ciprofloxacin was restricted to isolates from Asia (P 5 .001), whereas methicillin resistance predominated in isolates from the Pacific region (P 5 .04) ( Table 4) . In cluster no. 5, we observed a variation in the presence of methicillin resistance in an imported PVL 1 S. aureus strain (Table 3 ). The primary case had imported PVL 1 MSSA (t345) from India. A genotypically identical MRSA (ST772/t345) was isolated 4 weeks later from a skin lesion of the nontraveling Abbreviations: CI, confidence interval; OR, odds ratio from univariable logistic regression analysis using robust standard errors and comparing case patients with and without a given characteristic; PVL, Panton-Valentine leukocidin; S. aureus, Staphylococcus aureus; SSTI, skin and soft tissue infection. a 38 travelers (see Table 1 ) and 2 nontraveling contacts (see Table 3 ).
b Total number of patients with clinical characteristics (n 5 28) and total number of patients compared (n 5 39) because of missing data.
c From 2-sided Fisher exact test.
d Total number of patients compared (n 5 39) due to missing data.
e Total number of patients with S. aureus nasal carriage (n 5 28) and total number of patients compared (n 5 38) because of missing data.
f PVL 1 nasal carriage (n 5 14) and total number of patients compared (n 5 38) because of missing data.
g Total number of patients with surgical drainage (n 5 18) of a PVL 1 lesion (n 5 27) and total number of patients compared (n 5 37) because of missing data.
h Analysis of transmission to contacts restricted to 34 primary case patients; 4 traveling and 2 nontraveling secondary cases from clusters were excluded (see Table 4 ).
i Total number of patients with SSTIs in contacts (n 5 10) of S. aureus nasal carriage (n 5 24) and total number of patients compared (n 5 33) because of restriction to primary case patients and to missing data. k Total number of patients with SSTIs in contacts (n 5 10), PVL 1 nasal carriage (n 5 13), and total number of patients compared (n 5 33) because of restriction to primary case patients and to missing data. m Total number of patients with a PVL 1 lesion (n 5 24) and total number of patients compared (n 5 34) because of restriction to primary case patients and to missing data.
partner who had never traveled outside Europe. Independently from this cluster, we isolated a MRSA strain with the same genotype (ie, ST772/t345) in another returnee from India (Table 4 , no. 14).
DISCUSSION
Our study provides evidence for the introduction of PVL 1 S. aureus from the tropics and subtropics into the temperate zone. We show that returnees to Germany affected by S. aureuspositive SSTIs are likely to be infected and colonized with genotypes that are endemic or epidemic in the travel destination and, at the same time, are rarely found or completely unknown in central Europe. Forty-one percent ( . Both travelers were returning from India, where ST772 is currently emerging [33] . Most notably, this S. aureus genotype has also been reported in Britain in patients with family links to South Asia [34] . Finally, among case patients suffering from SSTIs caused by pandemic S. aureus clones (eg, CC5, CC30, ST121) [16] , the close temporal relationship between the onset of SSTIs in previously healthy individuals with exposure abroad suggests that PVL 1 S. aureus was imported; therefore, it is unlikely that the infections were the result of strains that were colonizing the traveler before the journey. None of the returnees who had remained free of skin infections while traveling were colonized with a PVL 1 isolate at the posttravel clinic visit. Thus, the import of such strains through colonization of travelers without a history of SSTIs appears to be uncommon. Prospective studies ascertaining the pretravel carriage status are indicated to determine whether the colonization of healthy returnees without a history of travelrelated SSTIs contributes to the global spread of PVL 1 S. aureus strains. Our study suggests that increased virulence of S. aureus acquired abroad is involved in the pathogenesis of travel-associated SSTIs. We show that recurrences and deep-seated abscesses were strongly associated with the presence of luk-PV genes in imported S. aureus, which is a finding that has also been reported in other populations [5] . There is considerable debate as to whether PVL, particularly when found in CA-MRSA, confers increased virulence itself or is merely associated with other yet unknown virulence determinants [49] [50] [51] . Our description of a consistent clinical phenotype in association with the presence of PVL 1 in S. aureus from diverse genetic backgrounds favors the independent role of PVL as a virulence factor for S. aureus, because close linkage with alternative virulence loci is less likely. Irrespective of this controversy, the association of PVL with complicated disease and antibiotic resistance suggests that its routine analysis in S. aureus isolates may be of considerable value in the clinical management of SSTIs in returning travelers. Most interestingly, this study illustrates that S. aureus from travel-associated SSTIs is frequently transmitted to close contacts and that spread of infection appears more likely in the presence of PVL. We noticed that secondary SSTIs could emerge in nontravelers even weeks after the primary case had returned [7] and during periods where the case patient was free of lesions. The trend toward an association of nasal carriage of PVL 1 S. aureus with the spread described in this study suggests that nasal carriage is important for the persistence of the pathogen during asymptomatic periods. Our results on the association of PVL nasal carriage with recurrent SSTIs, together with the existing evidence on the role of nasal S. aureus decolonization in preventing such recurrences [52] , suggest that asymptomatic returnees with a history of purulent skin infections abroad may benefit from decolonization when carrying PVL 1 S. aureus in their nares. We describe a significantly altered antibiotic susceptibility in imported PVL 1 MSSA strains when compared with colonizing PVL 2 MSSA. This finding is likely the consequence of increased antibiotic pressure and may reflect the geographic differences in antimicrobial agent use. In particular, the finding of an association between TMP-SMX resistance and travel to Asia and Africa is of immediate clinical relevance, because this compound is advocated as the antibiotic of choice for the empiric coverage of SSTIs in outpatients in the United States [53] and parts of Europe [54] where resistance against TMP-SMX in CA-MRSA was found to be low [54, 55] . Although incision and drainage is the therapy of choice for uncomplicated cases of SSTIs, future guidelines should acknowledge this finding to avoid the application of potentially ineffective TMP-SMX in returnees with complicated disease. Our observations are in line with the hypothesis expressed by others [13] [14] [15] [16] [17] MSSA may explain this observation given recent reports on the high prevalence of PVL in MSSA throughout the African continent [25, 27, 30, 56] . Similar conclusions were drawn by Stenhem et al [12] , who recently reported a substantially higher risk of importation of MRSA in returnees from the tropics and subtropics to Sweden. Most interestingly, they described the same 3 regions that we found to be most strongly associated with travel-related SSTI, namely Africa, the Middle East, and the Pacific region; these regions were also found to bear the highest risk for MRSA import [12] . This study has several limitations. First, we cannot rule out residual confounding of the main association (ie, travel destination and SSTI) by risk factors that were not assessed in this study. Second, we did not ascertain the sequence of events. Hence, the higher prevalence of S. aureus nasal carriage in case patients described in this study may be a consequence rather than a cause of SSTIs in travelers. Finally, traveler's diarrhea is known to be the leading cause of travel-associated morbidity, which explains the predominance of patients with gastrointestinal disorders in our control group. Because the risk of traveler's diarrhea is uniformly high in most destinations in the tropics and subtropics [57] , this choice of control for both the exposure to geographic regions and infectious disease risks abroad is likely to be a good representation of the population in which SSTI cases arose. Nevertheless, we would like to note that, on average, a lower risk for infectious enteritis as reported in Australia and the Pacific [57] may have led to a somewhat higher OR for SSTIs in returnees from this region compared with the estimates for other destinations.
SUMMARY AND CONCLUSIONS
The risk of SSTIs in travelers varies by destination and is higher in returnees from Africa. Complicated SSTIs in travelers returning from the tropics and subtropics are associated with PVL and promote the global spread of virulent and antibioticresistant S. aureus through secondary spread from lesions and colonization of the nares. Systematic surveillance and prompt treatment of travelers with complicated SSTIs may help prevent domestic transmission and the emergence of new highly virulent and multiply antibiotic-resistant S. aureus clones. We propose a collaborative network to facilitate the surveillance of such import, to study its potential public health impact, and to evaluate preventive interventions (www.staphtrav.eu).
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